These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37640958)

  • 1. Acute Effects of Single Versus Combined Inhaled β2-Agonists Salbutamol and Formoterol on Time Trial Performance, Lung Function, Metabolic and Endocrine Variables.
    Bizjak DA; Nussbaumer D; Winkert K; Treff G; Takabajashi K; Mentz L; Schober F; Buhl JL; John L; Dreyhaupt J; Steeb L; Harps LC; Parr MK; Diel P; Zügel M; Steinacker JM
    Sports Med Open; 2023 Aug; 9(1):79. PubMed ID: 37640958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ELSA trial: single versus combinatory effects of non-prohibited beta-2 agonists on skeletal muscle metabolism, cardio-pulmonary function and endurance performance-study protocol for a randomized 4-way balanced cross-over trial.
    Zügel M; Bizjak DA; Nussbaumer D; Winkert K; Takabayashi K; Kirsten J; Washington M; Treff G; Dreyhaupt J; Steeb L; Diel P; Parr MK; Steinacker JM; Persch H
    Trials; 2021 Dec; 22(1):903. PubMed ID: 34895300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular systolic function after inhalation of beta-2 agonists in healthy athletes.
    Persch H; Bizjak DA; Takabayashi K; Schober F; Winkert K; Dreyhaupt J; Harps LC; Diel P; Parr MK; Zügel M; Steinacker JM
    Sci Rep; 2024 Oct; 14(1):23437. PubMed ID: 39379505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can asthma treatment in sports be doping? The effect of the rapid onset, long-acting inhaled beta2-agonist formoterol upon endurance performance in healthy well-trained athletes.
    Carlsen KH; Hem E; Stensrud T; Held T; Herland K; Mowinckel P
    Respir Med; 2001 Jul; 95(7):571-6. PubMed ID: 11453313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β
    Jessen S; Reitelseder S; Kalsen A; Kreiberg M; Onslev J; Gad A; Ørtenblad N; Backer V; Holm L; Bangsbo J; Hostrup M
    J Appl Physiol (1985); 2021 Mar; 130(3):617-626. PubMed ID: 33357007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise performance after salbutamol inhalation in non-asthmatic, non-athlete individuals: a randomised, controlled, cross-over trial.
    Eckerström F; Rex CE; Maagaard M; Rubak S; Hjortdal VE; Heiberg J
    BMJ Open Sport Exerc Med; 2018; 4(1):e000397. PubMed ID: 30233808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
    van der Woude HJ; Winter TH; Aalbers R
    Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute impact of inhaled short acting b2-agonists on 5 km running performance.
    Dickinson J; Hu J; Chester N; Loosemore M; Whyte G
    J Sports Sci Med; 2014 May; 13(2):271-9. PubMed ID: 24790479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.
    Shepherd J; Rogers G; Anderson R; Main C; Thompson-Coon J; Hartwell D; Liu Z; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M
    Health Technol Assess; 2008 May; 12(19):iii-iv, 1-360. PubMed ID: 18485271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ergogenic effect of long-term use of high dose salbutamol.
    Dickinson J; Molphy J; Chester N; Loosemore M; Whyte G
    Clin J Sport Med; 2014 Nov; 24(6):474-81. PubMed ID: 24451697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combinatory in vitro effects of the β2-agonists salbutamol and formoterol in skeletal muscle cells.
    Piribauer M; Jiang L; Kostov T; Parr M; Steidel S; Bizjak DA; Steinacker JM; Diel P
    Toxicol Lett; 2023 Apr; 378():10-18. PubMed ID: 36822333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of long-acting β2-agonists plus inhaled corticosteroids for early reversibility in patients with airway obstruction.
    Ozkaya S; Dirican A; Tuna T
    J Thorac Dis; 2013 Aug; 5(4):461-5. PubMed ID: 23991303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant inhaled corticosteroid resensitises cardiac beta2-adrenoceptors in the presence of long-acting beta2-agonist therapy.
    Aziz I; McFarlane LC; Lipworth BJ
    Eur J Clin Pharmacol; 1998 Jul; 54(5):377-81. PubMed ID: 9754979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-acting beta2 agonists in the management of stable chronic obstructive pulmonary disease.
    Cazzola M; Donner CF
    Drugs; 2000 Aug; 60(2):307-20. PubMed ID: 10983735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined inhalation of beta2 -agonists improves swim ergometer sprint performance but not high-intensity swim performance.
    Kalsen A; Hostrup M; Bangsbo J; Backer V
    Scand J Med Sci Sports; 2014 Oct; 24(5):814-22. PubMed ID: 23834392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta2-Agonist Doping Control and Optical Isomer Challenges.
    Jacobson GA; Fawcett JP
    Sports Med; 2016 Dec; 46(12):1787-1795. PubMed ID: 27164986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do inhaled beta(2)-agonists have an ergogenic potential in non-asthmatic competitive athletes?
    Kindermann W
    Sports Med; 2007; 37(2):95-102. PubMed ID: 17241101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial.
    Papi A; Corradi M; Pigeon-Francisco C; Baronio R; Siergiejko Z; Petruzzelli S; Fabbri LM; Rabe KF
    Lancet Respir Med; 2013 Mar; 1(1):23-31. PubMed ID: 24321801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β₂-Agonists and physical performance: a systematic review and meta-analysis of randomized controlled trials.
    Pluim BM; de Hon O; Staal JB; Limpens J; Kuipers H; Overbeek SE; Zwinderman AH; Scholten RJ
    Sports Med; 2011 Jan; 41(1):39-57. PubMed ID: 21142283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indacaterol, a once-daily beta2-agonist, versus twice-daily beta₂-agonists or placebo for chronic obstructive pulmonary disease.
    Geake JB; Dabscheck EJ; Wood-Baker R; Cates CJ
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010139. PubMed ID: 25575340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.